These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Tissue plasminogen activator (tPA) inhibits plasmin degradation of fibrin. A mechanism that slows tPA-mediated fibrinolysis but does not require alpha 2-antiplasmin or leakage of intrinsic plasminogen. Wu JH, Diamond SL. J Clin Invest; 1995 Jun; 95(6):2483-90. PubMed ID: 7769094 [Abstract] [Full Text] [Related]
18. Incorporation of fragment X into fibrin clots renders them more susceptible to lysis by plasmin. Schaefer AV, Leslie BA, Rischke JA, Stafford AR, Fredenburgh JC, Weitz JI. Biochemistry; 2006 Apr 04; 45(13):4257-65. PubMed ID: 16566600 [Abstract] [Full Text] [Related]
19. [Functional characterization of a monoclonal antibody which interferes with the binding of t-PA to fibrin]. Orbe J, Montes R, Chordá C, Páramo JA, Rocha E. Sangre (Barc); 1994 Aug 04; 39(4):261-6. PubMed ID: 7985055 [Abstract] [Full Text] [Related]